Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2005 2
2006 1
2007 1
2008 1
2009 1
2010 1
2011 2
2012 2
2013 3
2014 2
2015 4
2016 3
2017 2
2018 4
2019 4
2020 2
2021 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Building a Personalized Cancer Treatment System.
Martinez A, López G, Bola Nos C, Alvarado D, Solano A, López M, Báez A, Quirós S, Mora R. Martinez A, et al. Among authors: quiros s. J Med Syst. 2017 Feb;41(2):28. doi: 10.1007/s10916-016-0678-z. Epub 2016 Dec 27. J Med Syst. 2017. PMID: 28028763
Study of the Diagnostic Delay of Tuberculosis in Spain.
Seminario A, Anibarro L, Sabriá J, García-Clemente MM, Sánchez-Montalván A, Medina JF, Mir I, Penas A, Caminero JA, Pérez GJ, Altet N, Domínguez Á, Jiménez-Fuentes MÁ, Quirós S, Tabernero EM, Souza-Galvão ML, Sáez A, Caylà JA, García-García JM, Rodrigo T; Working Group of the Integrated Tuberculosis Research Program (PII-TB) of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Seminario A, et al. Among authors: quiros s. Arch Bronconeumol (Engl Ed). 2021 Jun;57(6):440-442. doi: 10.1016/j.arbr.2021.04.006. Epub 2021 Apr 17. Arch Bronconeumol (Engl Ed). 2021. PMID: 34088404 No abstract available.
Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems-level property in cancer.
Bravo-Estupiñan DM, Aguilar-Guerrero K, Quirós S, Acón MS, Marín-Müller C, Ibáñez-Hernández M, Mora-Rodríguez RA. Bravo-Estupiñan DM, et al. Among authors: quiros s. Cancer Med. 2023 Dec;12(24):22130-22155. doi: 10.1002/cam4.6719. Epub 2023 Nov 21. Cancer Med. 2023. PMID: 37987212 Free PMC article. Review.
Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors.
Menéndez R, Méndez R, Latorre A, González-Jiménez P, Peces-Barba G, Molina M, España PP, García E, Consuegra-Vanegas A, Pando-Sandoval A, Panadero C, Figueira-Gonçalves JM, De la Rosa D, Sibila O, Martínez-Pitarch MD, Toledo N, Cejudo P, Almonte-Batista W, Macías-Paredes A, Badenes D, Pérez-Rodas EN, Lázaro J, Quirós S, Cordovilla R, Cano-Pumarega I, Torres A; RECOVID. Menéndez R, et al. Among authors: quiros s. J Intern Med. 2023 Jul;294(1):69-82. doi: 10.1111/joim.13642. Epub 2023 Apr 17. J Intern Med. 2023. PMID: 37038609 Free article.
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.
Borisov S, Danila E, Maryandyshev A, Dalcolmo M, Miliauskas S, Kuksa L, Manga S, Skrahina A, Diktanas S, Codecasa LR, Aleksa A, Bruchfeld J, Koleva A, Piubello A, Udwadia ZF, Akkerman OW, Belilovski E, Bernal E, Boeree MJ, Cadiñanos Loidi J, Cai Q, Cebrian Gallardo JJ, Dara M, Davidavičienė E, Forsman LD, De Los Rios J, Denholm J, Drakšienė J, Duarte R, Elamin SE, Escobar Salinas N, Ferrarese M, Filippov A, Garcia A, García-García JM, Gaudiesiute I, Gavazova B, Gayoso R, Gomez Rosso R, Gruslys V, Gualano G, Hoefsloot W, Jonsson J, Khimova E, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Marchese V, Martínez Robles E, Matteelli A, Mazza-Stalder J, Moschos C, Muñoz-Torrico M, Mustafa Hamdan H, Nakčerienė B, Nicod L, Nieto Marcos M, Palmero DJ, Palmieri F, Papavasileiou A, Payen MC, Pontarelli A, Quirós S, Rendon A, Saderi L, Šmite A, Solovic I, Souleymane MB, Tadolini M, van den Boom M, Vescovo M, Viggiani P, Yedilbayev A, Zablockis R, Zhurkin D, Zignol M, Visca D, Spanevello A, Caminero JA, Alffenaar JW, Tiberi S, Centis R, D'Ambrosio L, Pontali E, Sotgiu G, Migliori GB. Borisov S, et al. Among authors: quiros s. Eur Respir J. 2019 Dec 19;54(6):1901522. doi: 10.1183/13993003.01522-2019. Print 2019 Dec. Eur Respir J. 2019. PMID: 31601711 Free article.
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.
Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillén M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, Cadiñanos Loidi J, Cai Q, Caminero JA, Cebrian Gallardo JJ, Centis R, Codecasa LR, D'Ambrosio L, Dalcolmo M, Danila E, Dara M, Davidavičienė E, Davies Forsman L, De Los Rios Jefe J, Denholm J, Duarte R, Elamin SE, Ferrarese M, Filippov A, Ganatra S, Garcia A, García-García JM, Gayoso R, Giraldo Montoya AM, Gomez Rosso RG, Gualano G, Hoefsloot W, Ilievska-Poposka B, Jonsson J, Khimova E, Kuksa L, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Manga S, Marchese V, Martínez Robles E, Maryandyshev A, Matteelli A, Migliori GB, Mullerpattan JB, Munoz-Torrico M, Mustafa Hamdan H, Nieto Marcos M, Noordin NM, Palmero DJ, Palmieri F, Payen MC, Piubello A, Pontali E, Pontarelli A, Quirós S, Rendon A, Skrahina A, Šmite A, Solovic I, Sotgiu G, Souleymane MB, Spanevello A, Stošić M, Tadolini M, Tiberi S, Udwadia ZF, van den Boom M, Vescovo M, Viggiani P, Visca D, Zhurkin D, Zignol M; members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring. Akkerman O, et al. Among authors: quiros s. Int J Infect Dis. 2019 Jun;83:72-76. doi: 10.1016/j.ijid.2019.03.036. Epub 2019 Apr 3. Int J Infect Dis. 2019. PMID: 30953827 Free article.
37 results